Skip to main content
. 2017 Dec;7(Suppl 3):S207–S218. doi: 10.21037/cdt.2017.09.12

Table 1. Proposed mechanisms of statin effects.

Inflammation in thrombosis
   IL-6 (19)
   IL-8 (19)
   P-selectin (18)
   MCP-1 (18)
   TNF-alpha (21)
   CRP (19)
   D-dimer
Statins and biomarkers
   IL-6 (31)
   IL-8 (31)
   P-selectin (38)
   MCP-1 (31)
   CRP (32)
   eNOS
   Thrombomodulin (55)
   Apolipoprotein A1
   D-dimer
   PAI-1 (37)
   TF (42)
   MPO (42)
Statin antiplatelet effects
   Redox signaling interference (44)
   NADPH oxidase downregulation (45)
   Thromboxane A2 Inhibition (45)
   Peroxisome proliferator activated receptors (40)
   Decreased macrophage infiltration (42)
   Vein wall scarring (42)
   Inhibition of mevalonate pathway (48)
Statins and microvesicles
   TF inhibition (18)
   Procoagulant microparticle inhibition (48)
   Factor V inhibition (48)
   Statins and clot structure
   Alterations of fibrin clot structure (41)
   Increased clot permeability (52)
   Increased susceptibility to lysis (52)
Other
   Nets (42)
   Valve pocket sinus (18)

IL-6, interleukin 6; IL-8, interleukin 8; MCP-1, monocyte chemotactic protein 1; TNF-alpha, tumor necrosis factor alpha; CRP, C-reactive protein; PAI-1, plasminogen activator inhibitor-1; TF, tissue factor; MPO, myeloperoxidase; Nets, neutrophil extracellular traps; eNOS, endothelial nitric oxide synthase.